AUSTRAC has appointed an external auditor to Perth Mint, Australia’s official bullion mint, to assess its compliance with anti-money laundering and counter-terrorism financing laws.
The entity that employs the workforce of the On The Run convenience store chain has agreed to pay $5.8 million to settle a class action accusing it of underpaying over 8,000 workers over a six-year period.
Aussie group fitness chain Body Fit Training Company has been hit with a $3.2 million lawsuit for allegedly breaching an equipment supply agreement and diverting supplier Gym Imports’ rights as part of the $64.2 million sale of its business to US-based Xponential Fitness last year.
The state of Victoria can’t duck class action claims that failures in its hotel quarantine program caused businesses to suffer losses when stage three and four restrictions were put in place during the state’s second wave of COVID-19 cases in 2020.
Spirit Super and Palisade Investment Partners have withdrawn their $1.2 billion bid to acquire the Port of Geelong after the ACCC said the deal could substantially lessen competition in Victoria for the supply of bulk cargo port services.
UK automotive distributor Inchcape has challenged a judgment that put insurer Chubb on the hook for some but not all of the financial losses stemming from a cyberattack that allegedly caused $4 million in loss.
A judge has blasted Domino’s for its obstructionism in an underpayments class action and promised to order the pizza franchise giant to hand over information on its stores to facilitate settlement.
A joint venture formed to fund class action litigation has lost its bid for declarations against one of its former shareholders after arguing its former bankrupt director âineffectivelyâ transferred half of his shares.
Mercedes-Benz will face a penalty in ACCC proceedings alleging the luxury car maker exposed consumers to serious injury or death by failing to comply with obligations under a compulsory recall of potentially deadly Takata airbags.
Two law firms that filed competing class actions against regenerative medicine company Mesoblast for allegedly misleading shareholders about its Remestemcel-L treatment for COVID-19 complications have agreed to join forces and sidestep a beauty parade.